Summary The cellular response. in terms of cell cycle arrest(s) and apoptosis. to radiation-induced DNA damage was studied. Experiments were performed on both mitogen-stimulated and resting peripheral blood lymphocytes (PBLs) from normal and cancer-prone (C-P) individuals. The C-P individuals comprised three patients carrying germline p53 mutations and three members of two families apparently without such mutations, but with an inherited defect which results in p53 deregulation as shown by high levels of stabilised p53 protein in normal tissues. Interestingly, mitogen-stimulated PBL, from both normal and C-P individuals failed to demonstrate a G, arrest after gamma radiation. However, a clear difference was seen in the apoptotic response to DNA damage, of PBL from normal and C-P individuals; PBLs from C-P individuals with inherited p53-related defects had a reduced apoptotic response (P = 0.0003). There was a wide margin of separation, with no overlap between the two groups, supporting the possibility of using this altered apoptotic response as a screening test. This simple and rapid procedure could be used to identify those individuals in a C-P family who carry germline p53-related defects. The method appears to detect both individuals with p53 mutations and those apparently without mutations but with other p53-related defects.
p53 protein was discovered in 1979 by its property of binding to large T-antigen, the oncogene product of SV40 (Lane and Crawford, 1979; Linzer and Levine, 1979) . In recent years it has become clear that p53 plays a central role in the cellular processes involved in recognition of, and response to, DNA damage. Following a variety of noxious stimuli, such as gamma or UV irradiation, an accumulation of p53 is seen in the nuclei of normal cells (Kastan et al., 1991 Fritsche et al., 1993; Hall et al., 1993 ). The precise mechanisms by which p53 functions at the biochemical level are not yet clear but the recognition of DNA damage clearly involves more genes than p53 alone. p53 can act as a transcription factor for other genes and p53 protein forms complexes with a considerable number of other proteins. Recently, progress has been made in understanding the way in which p53 mediates apoptosis in cooperation with transcription factor E2F-1 (Wu and Levine, 1994) . Similarly, recent discoveries have contributed to the understanding of the mechanism by which p53 may control cell cycle progression, by controlling expression of the p21 cyclin-dependent kinase regulator (Waga et al., 1994) . The interactions are clearly complex but worthy of considerable study given the central role of p53 in maintaining genetic stability.
Kastan et al. (1991, 1992) and Kuerbitz et al. (1992) proposed a mechanism by which p53 might act to maintain genetic stability. They described experiments, in which proliferative cells with wild-type p53 exhibited an arrest of cells at the G, S boundary following DNA damage. Such a GI arrest was lost in cells with mutant p53. These workers suggested that in normal cells the G, arrest might allow time for damaged cells to repair DNA lesions before entering S-phase. In cells without functional p53, so this hypothesis goes, the failure to arrest in G, would lead to the genetic instability characteristic of tumours, by allowing cells with damaged DNA to replicate. It proliferation at all but rather be deleted via the process of apoptosis. p53 has been firmly implicated in this process following the induction of DNA damage (Clark et al., 1993; Lowe et al., 1993; Ryan et al., 1993) . Secondly, it is not certain that a GI arrest is necessary for the p53 induction of apoptosis (Hartwell, 1992; Lee and Bernstein, 1993) . YonishRouach et al. (1993) , using transfection of p53 deficient leukaemic cells with a temperature-sensitive mutant p53, demonstrated that p53-mediated apoptosis did not depend on G, arrest. Thus questions remain to be answered concerning the role of G, arrest: namely, is a G, arrest a necessary response to DNA damage in all cells with functional p53 and what is the importance of G, arrest in maintaining genetic stability of cells?
Over the past 25 years a syndrome has been recognised in which families exhibit a very precise pattern of cancer susceptibility (Li and Fraumeni, 1969; Li et al., 1988) involving early onset sarcomas, breast carcinoma, lymphoma and adrenal carcinoma; these families are said to exhibit Li-Fraumeni syndrome (LFS). In 1990 Malkin et al. demonstrated a relationship between p53 mutations and LFS. Since then the situation has become more complex as families with similar spectra of malignancies have been recognised, which do not fully meet the precise criteria for recognition as classical LFS. Such families have been called Li-Fraumenilike (LFL) (Birch et al., 1994) . Further, even in LFS, germline p53 mutations account for only 50-75% of cases and for LFL the figure is lower at about 10% (RA Eeles et al., in preparation). In some, at least, of the families which do not apparently have mutations in the p53 gene itself, there is evidence that p53 is deregulated due to an as yet unknown germline defect MacGeoch et al., 1995 (Birch et al.. 1994) . For details of the six C-P subjects see Table I (24) in exon 5 resulting in loss of 2. GIII infiltrating ductal carcinoma of proline (Eeles et al., 1995 (29) (Arg-*Trp) (Birch et al.. 1994) F (L)
1. Carcinoma breast (43) Mutation found at codon 245 in exon 2. Carcinoma breast (45) 7 GGC-*AGC (Gly-*Ser) (MacGeoch et al., 1995) G. Guy's Hospital; L, Leeds. Individuals C and D are from the same family, all other subjects are unrelated. Further information on the families can be obtained from the quoted references and if desired by request from the authors. None of these C-P individuals had received either chemo-or radiotherapy for a minimum of 4 years prior to the performance of these experiments; three of the five patients had never received such therapy. Figure  1 (a and b) Figure 1 (c and d) . As can be seen cells continue to move out of G1 through S-phase and into G2, where they are arrested. Data Gy. There is no evidence of a GI arrest after radiation, the cells having a normal S-phase fraction. Similar Figure 3 unlabelled GI cells have clearly entered S-phase confirming the lack of a GI arrest. This finding is confirmed by comparison of the cell cycle phase distributions after radiation with controls. In the control sample illustrated in Figure 3 cell cycle distributions was GI, 70%; S-phase, 23%; G2M, 7%. As described in the legend to Figure 3, Figure 4 illustrates the results of this procedure. From the four samples illustrated in Figure 4 , counts of intact and apoptotic lymphocytes were performed and the results compared with the flow cytometric measurements (see Table II ).
Apoptosis in stimulated PBLs
In all but one case, stimulated PBLs from normal individuals showed an increase in apoptotic cells following irradiation. This increase became apparent 8-13h after treatment and reached its peak 18-24h after radiation. However, the extent of the increase was extremely variable within the group of normal individuals and seemed to be inversely related to the level of stimulation. The lower the level of proliferation in a particular experiment, the greater was the increase in apoptotic cells ( Figure  5 ). The maximum apoptotic response was seen in unstimulated, irradiated PBLs.
Apoptosis in unstimulated PBLs Typical flow cytometric data are illustrated in Figure 6 ; the top two panels represent data from a normal individual, whilst the bottom two panels show equivalent data for a C-P individual. Quantitative results on the size of the increase in apoptotic cells for the eight normal and six C-P individuals studied are given in Table MII . A clear and highly significant difference is seen (P = 0.0003) with the C-P individuals having a much reduced apoptotic response following radiation. The abnormal apoptotic response was seen in C-P individuals irrespective of whether a p53 mutation had been demonstrated. The finding of a reduced apoptotic response in subject D was surprising because, although this individual is from a known cancerprone family (that of patient C-see Table I ), he was not thought to carry the defect since he had reached his seventies without developing a malignancy.
Dicssiom
When comparing the response, to DNA damage, of stimulated PBLs from normal and C-P individuals, no differences were seen in terms of cell cycle arrest(s). In all cases the expected G2 arrest was seen but no evidence of a G1
arrest was apparent in any experiment. Although it might seem initially surprising that stimulated PBLs from normal individuals failed to show a GI arrest, this may be related to conformational changes in p53. A number of reports in the At this time about 40% of }remining lymphocytes are apoptotic (see Table II ). (c) Unirradiated PBL from a C-P patient. (d) The same cells 24 h after 4 Gy, most cells appear viable but there is a small increase in apoptotic cells (see Table IT ).
literature have indicated that wild-type p53 undergoes a conformational change in lymphocytes following stimulation by mitogens (Milhr, 1984; Milner and Watson, 1990; Wu et al., 1993) . These studies involved the use of a panel of anti-p53 monoclonal antibodies some of which recognise the 'wildtype' conformation and some the 'mutant' conformation of the p53 protein. Donehower and Bradley (1993) A clear statistically significant difference was seen in the apoptotic response of unstimulated PBLs from the C-P subjects compared to that in a group of normal individuals. Clearly caution must be exercised given the moderate number of C-P individuals studied so far; further work is clearly called for. However, the results are consistent with a wide body of evidence that suggests functional p53 is required for switching DNA-damaged cells into apoptosis (see for example Clark et al., 1993; Lowe et al., 1993; Ryan et al.. 1993) . Although some of the C-P families appear to lack a p53 mutation, they all have p53-related defects (Table I) . Three of the C-P individuals studied come from families with proven p53 mutations (subjects A, E and F) and three are members of C-P families apparently without p53 mutations but with deregulation of p53 protein (individuals B. C and D). Both of the patients and affected members of their . There are insufficient data to allow any analysis of fine differences in response between C-P patients with and without a detected p53 mutation: all C-P individuals showed a marked reduction in apoptotic reponse after DNA damage. The clear difference in apoptotic response in unstimulated PBLs from normal and C-P individuals, with no overlap in the values obtained for the two groups, suggests the possibility that this response could form the basis of a screening test for individuals who might carry p53-related defects. Atrisk relatives of C-P patients could benefit from a test to determine whether they carry the. often unknown. inherited defect. p53 mutations are time consuming to isolate in Li-Fraumeni families and impossible to define in familites for whom the underlying nature of the p53-related cancer predisposition is not known. We suggest that a functional test of apoptotic response could be used as a cheap and rapid method to screen individuals for p53-related defects. Such an assay involves only modest labour and does not require extraction and manipulation of RNA or DNA from cells. The utility of such a test is highlighted by individual D (Table I) ; there was initial surprise that this individual showed a reduced apoptotic response after irradiation. This person. though from a recognised LFL family (that of patient C -see Table I ). was not thought to carry the unknown p53-related defect. as he is over 70 years of age and has no history of malignancy. Nevertheless. the reduced apoptotic response seen in PBLs from this subject raises the possibility that patient D may carry the defect exhibited in other members of his family despite his lack of malignant disease. It is known that a minority of Li-Fraumeni patients (about 10%) do not develop malignancies and after age 60 the risk of malignancy in such individuals is similar to that of normal individuals (Garber et al.. 1991 : Eeles. 1993 ).
